Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: Acohort study
(2020)
Journal Article
BACKGROUND: In studies including the general population, the presence of non-malignant monoclonal gammopathy (MG) can be causally associated with kidney damage and shorter survival. We assessed whether the presence of an MG is associated with a highe... Read More about Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: Acohort study.